CB Scientific, Inc. Concludes Its Annual Meeting of Stockholders
Shareholders endorse name change to Cardiac Biotech Solutions, Inc. subject to regulatory approvalLAS VEGAS, NV / ACCESSWIRE / March 19, 2024 / CB Scientific, Inc. (OTCQB:CBSC) ("CBSC" or the "Company
CB Scientific, Inc. Announces Exclusive Canadian Distribution Agreement
Your Heart Protector Corp. to market the Company's products and provide associated monitoring services throughout CanadaLAS VEGAS, NV / ACCESSWIRE / March 9, 2023 / CB Scientific. Inc. (OTCQB:CBSC) ("
Transdermal Drug Delivery Pipeline Report 2022 - ResearchAndMarkets.com
The "Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced MyCam Cardiac Event Monitor
Updated product to include significant operating improvements and material design advances over the current offeringESCONDIDO, CA / ACCESSWIRE / September 6, 2022 / CB Scientific. Inc.(OTCQB:CBSC) ("C
CB Scientific Inks Manufacturing Contract With Shenzhen Pump in China
CB Scientific (OTCQB:CBSC) signed an agreement under which Shenzhen Pump Medical will formally be recognized as the qualified manufacturer of record in China for the company's myCam cardiac event moni
CB Scientific, Inc. Enters Regulatory Testing Phase for Updated myCam Cardiac Event Monitoring Device
Enhanced product to include significant operating enhancements and material design advances over the current offeringESCONDIDO, CA / ACCESSWIRE / May 24, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC
CB Scientific, Inc. Welcomes James Ott as Chief Technology Officer
Newly created position to spearhead technological innovation in the next stage of growthESCONDIDO, CA / ACCESSWIRE / May 3, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designe
CB Scientific, Inc. Announces Uplist to the OTCQB(R) Venture Market
Shareholders to benefit from greater transparency and improved liquidityESCONDIDO, CA / ACCESSWIRE / April 6, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacture
CB Scientific, Inc. Concludes its Annual Audit with MaloneBailey, LLP
Achieving Major Milestone Squarely Positions the Company for Uplisting to the OTCQB® Venture MarketESCONDIDO, CA / ACCESSWIRE / March 15, 2022 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Com
CB Scientific, Inc. Concludes Its Special Meeting of Stockholders
Commanding shareholder approval better positions management to attain enterprise business objectives going forwardESCONDIDO, CA / ACCESSWIRE / January 18, 2022 / CB Scientific, Inc. (OTC PINK:CBSC) ("
CB Scientific, Inc. Enters Beta-testing Phase for Its Updated Proprietary My-Cam Cardiac Event Monitor
Updates to provide device improvements while maintaining the innovative core-functionality of CBSC's state-of-the-art cardiac event monitorESCONDIDO, CA / ACCESSWIRE / December 14, 2021 / CB Scientifi
CB Scientific, Inc. Announces Intent to Convene a Special Meeting of the Stockholders
Agenda to include matters necessary to better position the company for anticipated growth and developmentESCONDIDO, CA / ACCESSWIRE / November 30, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or
CB Scientific Files Application to Uplist to the OTCQB Venture Market
Upgraded listing would provide increased transparency and enhanced trading efficiencyESCONDIDO, CA / ACCESSWIRE / November 16, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Company") is p
No Data